000 01166 a2200349 4500
005 20250511204056.0
264 0 _c19920316
008 199203s 0 0 eng d
022 _a0031-6970
024 7 _a10.1007/BF00280108
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHertrampf, R
245 0 0 _aElimination of flecainide as a function of urinary flow rate and pH.
_h[electronic resource]
260 _bEuropean journal of clinical pharmacology
_c1991
300 _a61-3 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAmmonium Chloride
_xadministration & dosage
650 0 4 _aCarbonates
_xadministration & dosage
650 0 4 _aFlecainide
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aHydrogen-Ion Concentration
650 0 4 _aMale
650 0 4 _aUrine
_xchemistry
650 0 4 _aUrodynamics
700 1 _aGundert-Remy, U
700 1 _aBeckmann, J
700 1 _aHoppe, U
700 1 _aElsässer, W
700 1 _aStein, H
773 0 _tEuropean journal of clinical pharmacology
_gvol. 41
_gno. 1
_gp. 61-3
856 4 0 _uhttps://doi.org/10.1007/BF00280108
_zAvailable from publisher's website
999 _c1789374
_d1789374